Xiangxue Pharmaceutical Co.,Ltd.

SZSE:300147 주식 보고서

시가총액: CN¥8.6b

Xiangxue PharmaceuticalLtd 과거 수익 실적

과거 기준 확인 0/6

Xiangxue PharmaceuticalLtd's earnings have been declining at an average annual rate of -42.5%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 8% per year.

주요 정보

-42.5%

수익 성장률

-42.9%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률-8.0%
자기자본 수익률-22.1%
순이익-21.9%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%

Oct 15
Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%

Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry

Jul 31
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry

Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet

Jun 07
Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet

Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Mar 12
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%

수익 및 비용 분석

Xiangxue PharmaceuticalLtd 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SZSE:300147 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 242,105-46155898
30 Jun 242,194-45858196
31 Mar 242,279-42958989
31 Dec 232,299-38959190
30 Sep 232,170-37755776
30 Jun 232,197-42657983
31 Mar 232,162-47160399
01 Jan 232,187-53060395
30 Sep 222,480-1,004744105
30 Jun 222,626-909675109
31 Mar 222,793-76766292
01 Jan 222,971-68866091
30 Sep 212,814-3359982
30 Jun 212,791859968
31 Mar 213,0654259169
31 Dec 203,0729859067
30 Sep 203,29713257759
30 Jun 203,27816260863
31 Mar 202,93112661963
31 Dec 192,7867762161
30 Sep 192,6445762956
30 Jun 192,5965959242
31 Mar 192,5716160241
31 Dec 182,5045660439
30 Sep 182,4008762534
30 Jun 182,3037162456
31 Mar 182,2926957845
31 Dec 172,1876653040
30 Sep 172,1676047725
30 Jun 172,165614890
31 Mar 172,013574750
31 Dec 161,862664520
30 Sep 161,7001094290
30 Jun 161,5271374120
31 Mar 161,4181703800
31 Dec 151,4651773860
30 Sep 151,4701903720
30 Jun 151,5302003640
31 Mar 151,5462003670
31 Dec 141,5241973560
30 Sep 141,6022033270
30 Jun 141,5541933120
31 Mar 141,4081732880
31 Dec 131,2611582660

양질의 수익: 300147 is currently unprofitable.

이익 마진 증가: 300147 is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 300147 is unprofitable, and losses have increased over the past 5 years at a rate of 42.5% per year.

성장 가속화: Unable to compare 300147's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: 300147 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-1.2%).


자기자본 수익률

높은 ROE: 300147 has a negative Return on Equity (-22.05%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기